Metraipolis › archive › dc_4bc30b7a2f7f

TAFRO syndrome complicating Sjögren's disease: response to subcutaneous tocilizumab — Europe PMC PMID:42174299

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42174299
DOI
10.1007/s10067-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-01T09:07:35.521Z
SHA-256 of the archived text
e148dd0cc84a723c2924b62b779463559f19a440a384a2568180d45148c72450
Stable URL of this page
https://metraipolis.com/documento/dc_4bc30b7a2f7f

How to cite

TAFRO syndrome complicating Sjögren's disease: response to subcutaneous tocilizumab — Europe PMC PMID:42174299 — Europe PMC (en), https://europepmc.org/article/MED/42174299 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bc30b7a2f7f (Metraipolis archive dc_4bc30b7a2f7f, sha256 e148dd0cc84a723c2924b62b779463559f19a440a384a2568180d45148c72450)
BibTeX
@misc{dc4bc30b7a2f7f,
  title = {TAFRO syndrome complicating Sjögren's disease: response to subcutaneous tocilizumab — Europe PMC PMID:42174299},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42174299},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bc30b7a2f7f; sha256 e148dd0cc84a723c2924b62b779463559f19a440a384a2568180d45148c72450},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42174299. Agents can read the archived copy with the MCP tool read_document.